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gency department (ED) chief complaint; the majority of
clinical resources are directed toward detecting and treating
cardiopulmonary emergencies. However, at follow-up,
80%–95% of these patients have only a symptom-based
diagnosis; a large number have undiagnosed anxiety disor-
ders. Objective: Our aim was to measure the frequency of
self-identified stress or anxiety among chest pain patients,
and compare their pretest probabilities, care processes,
and outcomes. Methods: Patients were divided into two
groups: explicitly self-reported anxiety and stress or not at
90-day follow-up, then compared on several variables: ultra-
low (<2.5%) pretest probability, outcome rates for acute cor-
onary syndrome (ACS) and pulmonary embolism (PE),
radiation exposure, total costs at 30 days, and 90-day recid-
ivism. Results: Eight hundred and forty-five patients were
studied. Sixty-seven (8%) explicitly attributed their chest
pain to ‘‘stress’’ or ‘‘anxiety’’; their mean ACS pretest prob-
ability was 4% (95% confidence interval 2.9%–5.7%) and
49% (33/67) had ultralow pretest probability (0/33 with
ACS or PE). None (0/67) were diagnosed with anxiety. Seven
hundred and seventy-eight did not report stress or anxiety
and, of these, 52% (403/778) had ultralow ACS pretest prob-e: Agency for Health Research and Quality
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xiety. The Journal of Emergency Medicine, 52ability. Only one patient (0.2%; 1/403) was diagnosed with
ACS and one patient (0.4%; 1/268) was diagnosed with
PE. Patients with self-reported anxiety had similar radiation
exposure, associated costs, and nearly identical (25.4% vs.
25.7%) ED recidivism to patients without reported anxiety.
Conclusions: Without prompting, 8% of patients self-
identified ‘‘stress’’ or ‘‘anxiety’’ as the etiology for their chest
pain. Most had low pretest probability, were over-
investigated for ACS and PE, and not investigated for anxi-
ety syndromes.  2016 Elsevier Inc. All rights reserved.
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bolism; psychological conditionsINTRODUCTION
Patients who present with chest pain account for approx-
imately 7 million visits to United States (US) emergency
departments (EDs) (1). Emergency medicine providers
view chest pain as a high-risk complaint, as acute coro-
nary syndrome (ACS) and pulmonary embolism (PE)
are two entities included in the differential that are immi-
nent threats to life. Thus, most resources and clinical ef-
forts are focused on the detection and treatment ACS
and PE. However, between 80% and 95% of all patients
presenting to EDs with complaints of chest pain do not
have cardiac disease, or any other cardiopulmonary emer-
gency by conventional testing (2–6). Further, previous
findings indicate that up to 55% of patients wither 2016;
___________
form as:
monary Evaluation of Low-Risk Chest Pain Patients with Self-
(3), 273–279. https://doi.org/10.1016/j.jemermed.2016.11.022
2 P. I. Musey Jr. and J. A. Klinenon-cardiopulmonary chest pain may be suffering from
anxiety or panic disorders, and these psychiatric disorders
remain undiagnosed in almost 90% of cases (7–13). Costs
associated with the evaluation of chest pain found not to
be related to an emergent cardiopulmonary condition
have been estimated to be between $315 million and $8
billion per year, usually with no definitive cause
contributing to recurrent ED visits (14,15).
We sought to measure the frequency of self-identified
stress or anxiety among a large prospectively collected
cohort of patients presenting to the ED with chest pain
and compare their pretest probabilities, care processes,
and outcomes.METHODS
Study Design
This is an unplanned secondary analysis of a prospective
outcomes study from 4 centers including 851 participants
presenting to the ED with chest pain and shortness of
breath. This analysis relies on the methods, inclusion/
exclusion criteria, and data collection utilized in the
original outcomes study, which have been previously
published but will be summarized here (2).
Setting
The four centers from which data were collected included
3 academic hospitals (Carolinas Medical Center Main
Hospital, Charlotte, NC; University of Mississippi Med-
ical Center, Jackson, MS; and Beth Israel Deaconess
Medical Center, Boston, MA) and 1 community hospital
(Forsyth Hospital, Winston Salem, NC). The data
collection for this study took place between January
2010 and February 2013 and the ClinicalTrials.gov iden-
tifier is NCT01059500. The US Food and Drug Adminis-
tration investigational device exemption number is
IDE#125834. All sites obtained respective Institutional
Review Board approval.
Participants
Potential patients were identified at the participating hos-
pitals by research assistants viewing the electronic
tracking board in the ED for the chief complaint of ‘‘chest
pain’’ under a partial waiver of consent for screening. Pa-
tients eligible for enrollment included adults ($17 years
of age) presenting with chest pain or discomfort in addi-
tion to dyspnea. English-speaking patients were eligible,
as were Spanish-speaking patients with aid of a language
interpreter. Additionally, all patients had to have a
12-lead electrocardiogram (ECG) ordered by the treating
physician. Patients were excluded for the presence of anyof the following: an ECG computer interpretation of
ischemia or infarction, acute myocardial infarction, or
ST-elevation myocardial infarction; known diagnosis of
acute PE within the previous 24 h; recent or current
myocardial infarction; recent coronary artery bypass
grafting (within 30 days); other ‘‘obvious conditions or
diagnosis identified by the emergency physician as
mandating admission (evidence of circulatory shock,
severe hypoxemia, decompensated heart failure, altered
mental status, hemorrhage, sepsis syndrome, arrhythmia,
trauma, unstable social or psychiatric situation, stroke,
aortic disaster, or pneumonia)’’; cocaine use within
72 h; physician referral to ED specifically for admission;
patients requiring medical clearance secondary to a court
order or for referral to a detoxification center; individuals
visiting from out of town or with other situations thought
to be a hindrance to follow-up, such as homelessness;
individuals from jail or in police custody; and pregnant
patients (2). Individuals who left against medical advice,
were subsequently incarcerated within 14 days of their
visit, or who were objectively cocaine positive by testing
were subject to post-enrollment exclusion (2).
The method of attribute matching was used to estimate
each patient’s pretest probability for both ACS and PE
using clinical predictors (6,16). Attribute matching
uses computer software to match clinical predictors
entered by practitioners for ACS and PE (8 and 10,
respectively). This profile is entered into a web-based
computer program linked to two large databases of pa-
tients with chest pain and dyspnea (http://pretestconsult.
com/v21/acs and http://pretestconsult.com/v21/pe).
Those with exact profile matches were extracted,
providing both the denominator of all matches as well
as the number of those with either ACS or PE (numer-
ator), which in turn produced a numeric pretest probabil-
ity value. These values could be further be divided into
four subgroups (ultralow, 0 to < 2.5%; low, 2.5%–5.5%;
moderate, >5.5%–10%; and high, >10%) (2,17). These
patients were followed for outcomes out to 90 days
using structured medical record chart review, as well as
validated questionnaires administered by phone (2,18).
In addition to the administered validated question-
naires, all patients were asked ‘‘What do you believe
caused your chest pain?’’ at the end of the telephone
follow-up at 90 days. No further prompting was given
and the patients were allowed to answer freely, and an-
swers were recorded in the patient’s own words.
Variables
To test the main study question, patients were divided
into 2 groups: those who explicitly self-reported anxiety
or stress and those who did not (groups 1 and 2, respec-
tively). We then compared ultralow pretest probabilities
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PE diagnoses in this subgroup, total radiation exposure to
the chest (mSv), total costs at 30 days, and finally 90-day
returns to the ED, as well as observation and inpatient ad-
missions.
Radiation and Cost Data
Radiation doses were estimated from chest radiography,
cardiac and ventilation-perfusion scanning, computed to-
mography scanning, and fluoroscopy-guided studies (eg,
cardiac catheterization, upper gastrointestinal series)
(2,19,20). Medical cost data were collected from the
universal hospital claims submission form (UB-92
CMS-1450) with charges converted to cost using the
cost-to-charge ratio method, which relies on theMedicare
impact file to correct for markup (21). This method
excludes professional billing.
Statistical Methods
IBM SPSS software, version 23 (released 2013, IBM
Corp, Armonk, NY) was used for descriptive statistics
and analysis comparing means, medians, frequencies,
and proportions. The 95% confidence intervals for
these comparisons, including those of proportions,
are reported for illustration of effect size instead of
p values. Any missing case variables were
excluded from their respective analysis and noted in
the tables.Table 1. Group Assignment According Anxiety Self-Report and De
Variable
Group 1: Stres
(n =
Sex, n (%)
Female 32 (6.7
Male 35 (9.5
Race, n (%)
African American/black 35 (8.7
White 26 (7.7
American Indian 0 (0.0
Asian 0 (0.0
Other 3 (17.
Unknown 3 (5.1
Ethnicity, n (%)
Hispanic or Latino 7 (13.
Not Hispanic or Latino 60 (7.6
Age, y, mean (95% CI) 45.8 (42.
Acute coronary syndrome pretest probability,† %,
mean (95% CI)
4.3 (2.9
Pulmonary embolism pretest probability,† %,
mean (95% CI)
4.7 (3.6
ICD-9 diagnosis of anxiety, n (%) 0 (0)
CI = confidence interval; ICD-9 = International Classification of Disease
* Six subjects excluded (left against medical advice or before evaluatio
† Derived from attribute matching using clinical predictors for acute cor
ability values divided into 4 subgroups (0 to <2.5% ultralow, 2.5%–5.5RESULTS
FromDecember 2010 to February 2013, eight hundred and
fifty-one patients were enrolled. Six patients were
excluded from analysis because they either signed out
against medical advice or left before evaluation comple-
tion, leaving 845 for analysis. Patient characteristics, ex-
posures, bias mitigation, and potential confounders for
this population have been reported previously (2). Basic
demographic data is retabulated in Table 1 for comparison
according to the specified groups described in theMethods
section. When asked ‘‘What do you think caused your
chest pain?’’ Sixty-seven (8%; 95% confidence interval
[CI] 7.7%–8.3%) patients responded explicitly that they
believed their chest pain was caused by mental ‘‘stress’’
or ‘‘anxiety.’’ Examples of patient responses include: ‘‘It
was probably a panic attack’’; ‘‘I don’t know, I’ve been
under a lot of stress’’; ‘‘Fear and anxiety.’’ These patients
comprise Group 1 (Table 1) and their mean ACS pretest
probability was 4% (95% CI 2.9%–5.7%) with 49%
(95% CI 37.4%–61.2%) (33/67) having an ultralow
(<2.5%) ACS pretest probability, and none (0/67)
had ACS as shown in Table 2. The mean PE pretest prob-
ability was 5% (95% CI 3.6%–5.7%) with 46% (95% CI
34.4%–58.2%) (31/67) of patients having an ultralow PE
pretest probability and none (0/67) had PE. Additionally,
none (0/67) of these patients who believed their chest
pain was caused by mental stress or anxiety were actually
diagnosed with anxiety in the ED. Almost all received a
descriptive diagnosis, such as ‘‘chest pain.’’mographics
s or Anxiety
67)
Group 2: No Stress or Anxiety
(n = 778)
Totals
(n = 845)*
) 446 (93.3) 478 (56.6)
) 332 (90.5) 367 (43.4)
) 388 (91.7) 423 (50.1)
) 313 (92.3) 339 (40.1)
) 3 (100) 3 (0.4)
) 4 (100) 4 (0.5)
6) 14 (82.4) 17 (2.0)
) 56 (94.9) 59 (5.1)
7) 44 (86.3) 51 (6.0)
) 734 (92.4) 794 (94)
6–49.0) 49.1 (48.0–50.2) —
–5.7) 4.3% (3.9–4.7) —
–5.7) 5.7 (5.3–6.1) —
2 (100) 2 (0.2)
, 9th Revision.
n).
onary syndrome and pulmonary embolism. Numeric pretest prob-
% low, >5.5%–10% moderate, and >10% high).
Table 2. Descriptive Outcome Variable Comparisons
Variable
Group 1: Stress/Anxiety (n = 67) Group 2: No Stress/Anxiety (n = 778)
Median
(IQR)
Mean or n (%)
[95% CI]
Median
(IQR)
Mean or n (%)
[95% CI]
Ultralow (<2.5%) probability for ACS — 33 (49.3) [37.4–61.2] — 403 (51.8) [48.3–55.3]
Proportion diagnosed with ACS — 0 (0) — 1 (0.2) [0–0.6%]
Ultralow (<2.5%) probability for PE — 31 (46.3) [34.4–58.2] — 268 (34.4) [31.1–37.7]
Proportion diagnosed with PE — 0 (0) — 1 (0.4) [0–1.2]
Total radiation dose from chest imaging
within 90 days, mSv*
0.06 (0.06–8.02) 3.06 [1.78–4.34] 0.12 (0.06–8.06) 5.03 [4.14–5.92]
Chest radiation >5 mSv* 18 (27.2) [16.5–37.9] 296 (38.6) [35.2–42]
Total medical cost within 30 days, $†‡ 790 (5602,144) 2,609 [1,5923,626] 1,408 (6313,119) 3,587 [2,9544,221]
90-Day ED returns — 17 (25.4) [15.0–35.8] — 200 (25.7) [22.6–28.8]
90-Day observation admissions — 0 (0.0) — 13 (1.7) [1.0–2.6]
90-Day inpatient admissions — 2 (2.9) [1.8–4.0] — 81 (10.4) [8.3–12.5]
ACS = acute coronary syndrome; ED = emergency department; IQR = interquartile range; PE = pulmonary embolism.
* Subjects with missing radiation data (1 and 11 for groups 1 and 2, respectively).
† Does not include professional charges.
‡ Subjects with missing cost data (0 and 21 for groups 1 and 2, respectively).
4 P. I. Musey Jr. and J. A. KlineSeven hundred and seventy-eight (92%) patients
had no explicit mention of anxiety (Group 2) and their
demographics are shown in Table 1. The mean ACS
pretest probability for this group was 4%
(95% CI 3.9%–4.7%) and of these, 51.8% (95% CI
48.3%–55.3%) (403/778) had an ultralow ACS pretest
probability. Their mean PE pretest probability was 6%
(5.3%–6.1%) with 268 (34.4%; 95% CI 31.1%–37.7%)
having an ultralow pretest probability for PE. There
was one patient (0.2%; 95% CI 0%–0.6%; 1/403) with
an ultralow ACS probability diagnosed with ACS and
one patient (0.4%; 95% CI 0%–1.2%; 1/268) with an ul-
tralow PE probability diagnosed with PE. Only 2 of 778
(0.3%; 95% CI 0%–0.7%) patients who did not report
anxiety received an International Classification of Dis-
eases, 9th Revision (ICD-9), diagnosis of anxiety (22).
We compared the outcomes of total chest radiation
exposure (mSv), cost at 30 days, as well as 90-day returns
(ED, observation, and inpatient) between the two groups
shown in Table 2. Patients who self-reported anxiety had
costs estimated to be $2,609 (95% CI $1,592$3,626)
and mean total radiation exposure of 3.1 mSv (95% CI
1.8–4.3 mSv) with 18 (27.2%; 95% CI 16.5%–37.9%)
having > 5 mSv radiation exposure. While those who
did not explicitly endorse anxiety had costs of $3,587
(95% CI $2,954$4,221) and mean radiation exposure
of 5.0 mSv (95% CI 4.1–5.9 mSv) with 296 (38.6%;
95% CI 35.2%–42%) having > 5 mSv radiation exposure.
With regard to 90-day returns, patients with self-reported
anxiety had 17 (25.4%; 95% CI 15.0%–35.8%) ED re-
turns, zero observation admissions, and 2 (3%; 95% CI
1.8%–4.0%) inpatient admissions. Those without anxiety
report had a total of 200 (25.7%; 95% CI 22.6%–28.8%)
ED returns, 13 (1.7%; 95% CI 1.0%–2.6%) observationadmissions, and 81 (10.4%; 95% CI 8.3%–12.5%)
inpatient admissions within 90 days.
DISCUSSION
We found that 67 of 845 (8%) patients volunteered anxi-
ety as the cause of their chest pain evaluated 90 days pre-
viously. None of these patients had ACS or PE, and their
radiation exposure, costs, and recidivism rates were
similar to patients who did not volunteer anxiety. None
of the 67 patients with self-perceived anxiety were treated
for anxiety or given a diagnosis of anxiety. These findings
suggest that usual ED care to exclude ACS and other car-
diopulmonary emergencies may not always serve patients
optimally. Usual care can require 648 h, multiple tests,
radiation exposure, and high costs (23). Despite this, an
overwhelmingly majority of these patients do not have
ACS, PE, or other cardiopulmonary emergencies (26).
This is especially important, as studies suggest that the
majority of patients with noncardiac chest pain may
develop chronic chest pain and continue to seek medical
attention despite negative cardiac evaluations and reas-
surance (24,25). Further, a significant number of these
patients with noncardiac chest pain may have
underlying anxiety or panic, which are driving their
symptoms (7–13).
A striking observation was that there were only 2 of
845 patients in the entire cohort who were given an
ICD-9 diagnosis of anxiety or similar, and we believe
that many more patients beyond the 67 with self-
awareness probably had undiagnosed anxiety. That no
patients who self-identified anxiety were diagnosed as
such implies a missed opportunity for providers to
have detected anxiety simply by asking the patient.
ED Chest Pain Evaluation of Patients with Self-Reported Anxiety 5Prior work has shown that a central feature of future
Diagnostic and Statistical Manual of Mental Disorders,
4th edition anxiety disorder diagnoses begins with
reliable self-report (26–28). Our work adds to the
work of Webster et al., who administered standardized
psychometric and quality of life testing to chest pain
patients both in the ED and at 1-month post-ED visit
(29). The authors found that overall, chest pain patients
scored higher than normative values would predict,
and 17% had ‘‘moderately severe’’ anxiety scores.
Further, higher baseline anxiety scores correlated with
more frequent chest pain at 1-month follow-up (29).
We believe the finding in our study of 8% of patients
essentially ‘‘self-diagnosing’’ anxiety 90 days later is
consistent with the findings by Webster et al. and others
showing frequent psychological distress in patients with
noncardiac chest pain (3,29,30). Detection and
treatment of anxiety and panic syndromes may help
forestall development of chronic chest pain, and
recurrent desire for medical reassurance, despite
negative cardiac evaluations.
Many clinicians believe that the medical community
fosters a culture of persecution for diagnosing anxiety in
a patient who has a true emergency. Our data also sug-
gest the possible use of pretest probability to bolster the
confidence of clinicians in raising the issue of anxiety.
Almost half (49% and 46%) of patients with self-
identified anxiety had an ultralow pretest probability
for ACS and PE, respectively, and no patient with ultra-
low pretest probability and self-reported anxiety had a
cardiopulmonary emergency. We note that, in fact, no
patient with self-reported anxiety had a cardiopulmo-
nary emergency. However, a substantial proportion of
patients with anxiety received > 5.0 mSv radiation,
with high cost of medical care.
We hypothesized that patients in our anxiety/stress
cohort (Group 1) would have higher levels of recidivism
than patients without self-identified anxiety or signifi-
cant cardiopulmonary diagnoses (Group 2). We actually
observed that there were no significant differences for
90-day returns to the ED for evaluation or for observa-
tion admissions within 90 days: approximately 25% in
both groups. With regard to inpatient admissions, it
does appear that Group 2 patients were more likely to
have a hospital readmission within 90 days. This, how-
ever, is not surprising, given the fact that virtually every
patient diagnosed with a cardiopulmonary emergency
was in Group 2, which is to be expected, given that pa-
tients with these conditions would be less likely to
volunteer anxiety as their main problem. These results
highlight the fact that, despite the frequently low risk,
these self-identified anxiety patients have essentially
the same rate of return to the ED for re-evaluation.Limitations
This was an unplanned secondary analysis of a prospec-
tively collected dataset. Thus, while answers to the
question about the reason for their chest pain were
collected prospectively, patients were not specifically
asked about stress or anxiety at either enrollment in
the ED or follow-up. Thus, we have no data from the
day of enrollment to determine whether patients
perceived the presence of anxiety, which would likely
have altered the proportions of patients assigned to
each group. Additionally, those patients providing re-
sponses at the 90-day follow-up presumably had the
benefit of knowing the outcome of their evaluation
and may have even come to their conclusions about
the cause of their chest pain because of their negative
evaluation.
CONCLUSIONS
Anxiety was perceived as an obvious problem to 8% of
patients 90 days after evaluation for dyspnea and chest
pain. That none of these patients had a serious diag-
nosis, none were treated for anxiety, and one-quarter re-
turned for medical care within 90 days implies a missed
opportunity to detect a treatable condition in patients
who seldom receive an actionable diagnosis.REFERENCES
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1. Why is this topic important?
Despite extensive evaluation involving multiple tests,
radiation exposure, and high cost an overwhelming major-
ity of patients seen for chest pain in the emergency depart-
ment do not have acute coronary syndrome, pulmonary
embolism, or other cardiopulmonary emergencies.
Further, it has been suggested that a significant number
of these patients with noncardiac chest pain may have un-
derlying anxiety or panic that drive their symptoms and
are often undiagnosed.
2. What does this study attempt to show?
To measure the frequency of self-identified stress and
anxiety among a large prospectively collected cohort of
chest pain patients at 90-day follow-up, and compare their
pretest probabilities, care processes, and outcomes to
those who did not self-identify anxiety.
3. What are the key findings?
In our study, anxiety was an obvious problem to 8% of
patients at follow-up evaluation. None of these patients
had a serious diagnosis, none were diagnosed with or
treated for anxiety, and one-quarter returned for medical
care within 90 days. Additionally, this group of patients
had similar radiation exposure and costs compared with
patients without the self-report of anxiety.
4. How is patient care impacted?
These results may highlight an opportunity, often
missed, to detect a treatable condition in patients who
seldom receive an actionable diagnosis.
